MedTrace Logo

Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute

NCT05607186 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2022-11-07

No results posted yet for this study

Summary

This is a retrospective cohort study that aims to evaluate the correlation of magnetic resonance tumour regression grade (mrTRG) and pathological TRG (pTRG) of locally advanced rectal cancer after neoadjuvant long course chemoradiotherapy as well as the prognostic value of mrTRG on survival.

Conditions

Interventions

RADIATION

neoadjuvant long course chemoradiotherapy

neoadjuvant long course chemoradiotherapy consist of radiosensitizing 5FU or capecitabine and 50.4 Gy in 28 fractions over 5 weeks

Sponsors & Collaborators

  • Singapore General Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-01
Primary Completion
2016-12-31
Completion
2019-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05607186 on ClinicalTrials.gov